MaxCyte Investor Presentation Deck

Example: Typical Single-Product Revenues from a Representative License Deal F Commercial Phase Low single digit % share of sales, including sales-based payments, annual instrument fees and disposable sales Approval: Year 5+ Multiple 7-figure milestones Mid-late Clinical: (Phase 2/3) Years 3-5+ 7-figure milestone per product increasing instrument and disposables usage Early Clinical: (Phase 1/2) Years 1-3 Mid-6-figure to Low-7-figure milestones 1-3+ instruments + disposables 12 M MaxCyte Cell Therapy Partner Program Value Schematic Instruments and Processing Assemblies Milestones Sales-Based Payments © 2023 MaxCyte, Inc. All Rights Reserved

View entire presentation